secwatch / observer
8-K filed April 12, 2024, 7:59 PM ET ticker OFIX CIK 0000884624
leadership confidence high sentiment neutral materiality 0.50

Three Orthofix directors to leave board at 2024 annual meeting

Orthofix Medical Inc.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Catherine M. Burzik

Director
OFIX · Orthofix Medical Inc.
Filed
April 12, 2024, 7:59 PM ET
Catherine M. Burzik has confirmed to the Board, consistent with the decision announced in November 2023, that she will not stand for re-election to the Board at the Annual Meeting.
Departed

Stuart M. Essig

Director
OFIX · Orthofix Medical Inc.
Filed
April 12, 2024, 7:59 PM ET
each of Stuart M. Essig, Ph.D. and James F. Hinrichs informed the Board of Directors (the “Board”) of Orthofix Medical Inc. (the “Company”) that they have elected not to stand for re-election to the Board at the Company’s 2024 annual meeting of shareholders in June 2024 (the “Annual Meeting”).
Departed

James F. Hinrichs

Director
OFIX · Orthofix Medical Inc.
Filed
April 12, 2024, 7:59 PM ET
each of Stuart M. Essig, Ph.D. and James F. Hinrichs informed the Board of Directors (the “Board”) of Orthofix Medical Inc. (the “Company”) that they have elected not to stand for re-election to the Board at the Company’s 2024 annual meeting of shareholders in June 2024 (the “Annual Meeting”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Catherine M. Burzik departed as Director at Orthofix Medical Inc..

Action
confirmed not to stand for re-election
Role
Director
Exact text from the filing
Catherine M. Burzik has confirmed to the Board, consistent with the decision announced in November 2023, that she will not stand for re-election to the Board at the Annual Meeting.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Stuart M. Essig departed as Director at Orthofix Medical Inc..

Action
elected not to stand for re-election
Role
Director
Exact text from the filing
each of Stuart M. Essig, Ph.D. and James F. Hinrichs informed the Board of Directors (the “Board”) of Orthofix Medical Inc. (the “Company”) that they have elected not to stand for re-election to the Board at the Company’s 2024 annual meeting of shareholders in June 2024 (the “Annual Meeting”).
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

James F. Hinrichs departed as Director at Orthofix Medical Inc..

Action
elected not to stand for re-election
Role
Director
Exact text from the filing
each of Stuart M. Essig, Ph.D. and James F. Hinrichs informed the Board of Directors (the “Board”) of Orthofix Medical Inc. (the “Company”) that they have elected not to stand for re-election to the Board at the Company’s 2024 annual meeting of shareholders in June 2024 (the “Annual Meeting”).
View on SEC.gov

Orthofix Medical Inc. filing history →

Source: SEC EDGAR
accession 0000950170-24-044082
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.